Choice of P2Y12 inhibitor and clinical outcomes in the AUGUSTUS study: support for an individualised approach

29 August 2020 (00:00 - 00:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Professor Robert Storey

University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail

Time trends in risk factor control and use of secondary preventive medication among patients with myocardial infarction attending cardiac rehabilitation: data from the SWEDEHEART registry 2006-2017

Associate Professor M. Leosdottir (Malmo, SE)

Abstract Slides Video

Presentation thumbnail

Identifying high thrombotic risk in atrial fibrillation patients undergoing percutaneous coronary intervention: is there a benefit of triple therapy?

Mr W. Bor (Nieuwegein, NL)

Abstract Slides Video

Presentation thumbnail

Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial

Doctor T. Vanassche (Leuven, BE)

Abstract Slides Video

Presentation thumbnail

Ten-year all-cause death in elderly patients undergoing percutaneous coronary intervention or coronary artery bypass grafting: A prespecified subgroup analysis of the SYNTAX Extended Survival study

Doctor M. Ono (Amsterdam, NL)

Abstract Slides Video

Presentation thumbnail

Residual functional SYNTAX score by quantitative flow ratio and improvement of exercise capacity after revascularization in patients with stable ischemic heart disease

Doctor S. Lee (Gwangju, KR)

Abstract Slides Video

Access the full session

Session thumbnail

Optimizing Management of Chronic CAD – Squeeze on Big Data for Additional Info

The Event

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources